For Companies

Build a capital sequence the company can execute.

For deep-tech, healthtech, dual-use, and innovation-driven companies aligning non-dilutive, venture, and strategic capital around measurable technical and commercial milestones.

Failure Modes

Where conversion breaks down.

These are the patterns that show up first, and the ones that cost the most to correct late.

01

Federal and equity strategies operate separately

Non-dilutive pursuit sits with a grants lead while the round sits with the CEO. Neither plan prices the other, so federal awards fund work the equity story never claims credit for.

02

The next raise depends on milestones the plan does not expose

The round is timed to a runway date rather than to the technical or commercial proof point that changes the valuation conversation.

03

Diligence evidence is assembled reactively

Cap table, regulatory assumptions, reimbursement logic, security posture, and customer evidence are rebuilt for each investor instead of maintained as a standing asset.

04

No senior operator owns the integrated capital pipeline

Capital work is distributed across a founder, a consultant, and a part-time writer. No one is accountable for conversion across the whole stack.

What Forged Catalyst Builds

Systems, not recommendations.

Sequenced capital architecture

A written 24-month sequence that assigns every source — federal, venture, strategic, customer — a specific risk it is responsible for removing, with trigger points and owners.

Ranked federal pursuit map

Agency and program fit measured against the actual technical position, with go / no-go discipline so the team stops spending six-week blocks on low-probability submissions.

Evidence and diligence-readiness system

A maintained data room, cap-table integrity, and an evidence standard that survives institutional review — built once, reused across every capital conversation.

Fractional Chief Capital Officer leadership

Embedded senior ownership of the integrated pipeline when capital complexity has outgrown founder-led execution.

Proof

Related work — Capital Readiness Program

A diligence-first capital readiness model built around live investor exposure rather than pitch practice. Eleven cohorts completed and 110 companies supported; alumni companies have reported raising more than $173M according to University City Science Center reporting.

Public program outcomes as reported by the program operator. Not represented as solely attributable to Forged Catalyst.

Selected institutions across prior leadership, advisory work, and programs

  • National Science Foundation
  • National Institutes of Health
  • U.S. Small Business Administration
  • U.S. Department of State
  • European Investment Fund
  • The Engine / Builder Platform
  • Kauffman Foundation
  • MD Anderson Cancer Center

Inclusion reflects prior leadership, program, advisory, investment, or institutional work. It does not imply current endorsement, partnership, or client status.

Fitting Engagements

Start narrow. Escalate only when the work justifies it.

Companies running federal, venture, and strategic capital simultaneously typically need an owner before they need another advisor.

011–2 weeks

Capital Conversion Snapshot

$4,750

A focused diagnostic identifying where capital conversion is breaking down, what is constraining progress and which interventions should be prioritized.

023–4 weeks

Capital Strategy Brief

$10,000–$15,000

A decision-grade capital and commercialization strategy covering opportunity alignment, funding architecture, institutional positioning and execution priorities.

036–12 weeks

Strategy & Pursuit Architecture

From $30,000

For complex federal pursuits, capitalization strategies, institutional programs, funds and multi-party initiatives.

04Flagship engagement · Ongoing

Fractional Chief Capital Officer

Custom Retainer

Senior operating leadership for organizations that need sustained capital strategy, institutional alignment and execution without adding a full-time executive.

Related Insight

Operator intelligence for this context.

Operator Note5 min read

Healthtech Capital Readiness Begins Before the Pitch

Healthtech rounds fail on documentation, reimbursement logic, and security posture — not on the deck. What readiness looks like when it is treated as an operating state.

Read the note

Engage

Find the binding constraint before the next raise is priced.

The Capital Strategy Diagnostic takes about ten minutes and returns a structured read on sequencing, evidence, and ownership gaps.